139 related articles for article (PubMed ID: 37663709)
21. Assessment of beta-catenin expression by immunohistochemistry in colorectal neoplasms and its role as an additional prognostic marker in colorectal adenocarcinoma.
Bhattacharya I; Barman N; Maiti M; Sarkar R
Med Pharm Rep; 2019 Jul; 92(3):246-252. PubMed ID: 31460505
[TBL] [Abstract][Full Text] [Related]
22. Matrix metalloproteinase 2 overexpression and prognosis in colorectal cancer: a meta-analysis.
Shi M; Yu B; Gao H; Mu J; Ji C
Mol Biol Rep; 2013 Jan; 40(1):617-23. PubMed ID: 23184003
[TBL] [Abstract][Full Text] [Related]
23. A pilot study on faecal MMP-9: a new noninvasive diagnostic marker of colorectal cancer.
Annaházi A; Ábrahám S; Farkas K; Rosztóczy A; Inczefi O; Földesi I; Szűcs M; Rutka M; Theodorou V; Eutamene H; Bueno L; Lázár G; Wittmann T; Molnár T; Róka R
Br J Cancer; 2016 Mar; 114(7):787-92. PubMed ID: 26908323
[TBL] [Abstract][Full Text] [Related]
24. Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.
Ring P; Johansson K; Höyhtyä M; Rubin K; Lindmark G
Br J Cancer; 1997; 76(6):805-11. PubMed ID: 9310250
[TBL] [Abstract][Full Text] [Related]
25. The diagnostic value of matrix metalloproteinase 9 (MMP-9) and tissue inhibitor of matrix metalloproteinases 1 (TIMP-1) determination in the sera of colorectal adenoma and cancer patients.
Mroczko B; Groblewska M; Okulczyk B; Kedra B; Szmitkowski M
Int J Colorectal Dis; 2010 Oct; 25(10):1177-84. PubMed ID: 20556397
[TBL] [Abstract][Full Text] [Related]
26. Serum matrix-metalloproteinase-1 is a bona fide prognostic marker for colorectal cancer.
Tahara K; Mimori K; Iinuma H; Iwatsuki M; Yokobori T; Ishii H; Anai H; Kitano S; Mori M
Ann Surg Oncol; 2010 Dec; 17(12):3362-9. PubMed ID: 20617463
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinase-8 rs11225395 polymorphism correlates with colorectal cancer risk and survival in a Chinese Han population: a case-control study.
Tai J; Sun D; Wang X; Kang Z
Aging (Albany NY); 2020 Oct; 12(19):19618-19627. PubMed ID: 33052136
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal transition in colorectal cancer tissue of patients with Lynch syndrome.
Gu GL; Zhu XQ; Wei XM; Ren L; Li DC; Wang SL
World J Gastroenterol; 2014 Jan; 20(1):250-7. PubMed ID: 24415879
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625
[TBL] [Abstract][Full Text] [Related]
30. The analysis between clinicopathological aspect of early-onset vs. late-onset colorectal cancer and mortality rate: a cross-sectional study.
Lukman K; Mulyawan A; Nugrahani AD; Rudiman R; Primastari E
Ann Med Surg (Lond); 2023 Jun; 85(6):2496-2501. PubMed ID: 37363503
[TBL] [Abstract][Full Text] [Related]
31. Clinicopathological and prognostic significance of α5β1-integrin and MMP-14 expressions in colorectal cancer.
Yang B; Gao J; Rao Z; Shen Q
Neoplasma; 2013; 60(3):254-61. PubMed ID: 23373994
[TBL] [Abstract][Full Text] [Related]
32. Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients.
Maurel J; Nadal C; Garcia-Albeniz X; Gallego R; Carcereny E; Almendro V; Mármol M; Gallardo E; Maria Augé J; Longarón R; Martínez-Fernandez A; Molina R; Castells A; Gascón P
Int J Cancer; 2007 Sep; 121(5):1066-71. PubMed ID: 17487834
[TBL] [Abstract][Full Text] [Related]
33. Association of superoxide dismutase enzyme with staging and grade of differentiation colorectal cancer: A cross-sectional study.
Warsinggih ; Irawan B; Labeda I; Lusikooy RE; Sampetoding S; Kusuma MI; Uwuratuw JA; Syarifuddin E; Prihantono ; Faruk M
Ann Med Surg (Lond); 2020 Oct; 58():194-199. PubMed ID: 32994983
[TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinase-9 expression in the normal mucosa-adenoma-dysplasia-adenocarcinoma sequence of the colon.
Herszényi L; Sipos F; Galamb O; Solymosi N; Hritz I; Miheller P; Berczi L; Molnár B; Tulassay Z
Pathol Oncol Res; 2008 Mar; 14(1):31-7. PubMed ID: 18347934
[TBL] [Abstract][Full Text] [Related]
35. Loss of basement membrane type IV collagen is associated with increased expression of metalloproteinases 2 and 9 (MMP-2 and MMP-9) during human colorectal tumorigenesis.
Zeng ZS; Cohen AM; Guillem JG
Carcinogenesis; 1999 May; 20(5):749-55. PubMed ID: 10334190
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-2 (-1306 c>t) promoter polymorphism and risk of colorectal cancer in the Saudi population.
Saeed HM; Alanazi MS; Parine NR; Shaik J; Semlali A; Alharbi O; Azzam N; Aljebreen A; Almadi M; Shalaby MA
Asian Pac J Cancer Prev; 2013; 14(10):6025-30. PubMed ID: 24289619
[TBL] [Abstract][Full Text] [Related]
37. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients.
Tutton MG; George ML; Eccles SA; Burton S; Swift RI; Abulafi AM
Int J Cancer; 2003 Nov; 107(4):541-50. PubMed ID: 14520690
[TBL] [Abstract][Full Text] [Related]
38. Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis.
Fernandez-Garcia B; Eiró N; Marín L; González-Reyes S; González LO; Lamelas ML; Vizoso FJ
Histopathology; 2014 Mar; 64(4):512-22. PubMed ID: 24117661
[TBL] [Abstract][Full Text] [Related]
39. The relationship between primary colorectal cancer histology and the histopathological growth patterns of corresponding liver metastases.
Höppener DJ; Stook JPL; Galjart B; Nierop PMH; Nagtegaal ID; Vermeulen PB; Grünhagen DJ; Verhoef C; Doukas M;
BMC Cancer; 2022 Aug; 22(1):911. PubMed ID: 35996090
[TBL] [Abstract][Full Text] [Related]
40. Matrix metalloproteinase 13 activity is associated with poor prognosis in colorectal cancer.
Leeman MF; McKay JA; Murray GI
J Clin Pathol; 2002 Oct; 55(10):758-62. PubMed ID: 12354802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
